![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=0924-977X&client=dukeuniv)
P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels
Publication
, Conference
Madhoo, M; Roth, RM; Keefe, RSE; Sambunaris, A; Scheckner, B; Nielsen, J; Adeyi, B; Wu, J; Lasser, R
Published in: European Neuropsychopharmacology
October 2012
Duke Scholars
Published In
European Neuropsychopharmacology
DOI
ISSN
0924-977X
Publication Date
October 2012
Volume
22
Start / End Page
S233 / S234
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Madhoo, M., Roth, R. M., Keefe, R. S. E., Sambunaris, A., Scheckner, B., Nielsen, J., … Lasser, R. (2012). P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels. In European Neuropsychopharmacology (Vol. 22, pp. S233–S234). Elsevier BV. https://doi.org/10.1016/s0924-977x(12)70346-2
Madhoo, M., R. M. Roth, R. S. E. Keefe, A. Sambunaris, B. Scheckner, J. Nielsen, B. Adeyi, J. Wu, and R. Lasser. “P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels.” In European Neuropsychopharmacology, 22:S233–34. Elsevier BV, 2012. https://doi.org/10.1016/s0924-977x(12)70346-2.
Madhoo M, Roth RM, Keefe RSE, Sambunaris A, Scheckner B, Nielsen J, et al. P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels. In: European Neuropsychopharmacology. Elsevier BV; 2012. p. S233–4.
Madhoo, M., et al. “P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels.” European Neuropsychopharmacology, vol. 22, Elsevier BV, 2012, pp. S233–34. Crossref, doi:10.1016/s0924-977x(12)70346-2.
Madhoo M, Roth RM, Keefe RSE, Sambunaris A, Scheckner B, Nielsen J, Adeyi B, Wu J, Lasser R. P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels. European Neuropsychopharmacology. Elsevier BV; 2012. p. S233–S234.
![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=0924-977X&client=dukeuniv)
Published In
European Neuropsychopharmacology
DOI
ISSN
0924-977X
Publication Date
October 2012
Volume
22
Start / End Page
S233 / S234
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences